Quarterly report pursuant to Section 13 or 15(d)

Note 13 - Stockholders' Equity (Details)

v2.4.0.8
Note 13 - Stockholders' Equity (Details) (USD $)
 9 Months Ended
Mar. 31, 2014
Note 13 - Stockholders' Equity (Details) [Line Items]  
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 2,400
Allocated Share-based Compensation Expense $ 17,424
Restricted Stock Units (RSUs) [Member] | Officer [Member]
  
Note 13 - Stockholders' Equity (Details) [Line Items]  
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 40,000
Allocated Share-based Compensation Expense 427,200
Restricted Stock Units (RSUs) [Member] | Director [Member]
  
Note 13 - Stockholders' Equity (Details) [Line Items]  
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 3,448
Allocated Share-based Compensation Expense 36,826
Settlement of Payable [Member]
  
Note 13 - Stockholders' Equity (Details) [Line Items]  
Debt Conversion, Converted Instrument, Shares Issued 27,000
Debt Conversion, Converted Instrument, Amount 210,060
Employees [Member]
  
Note 13 - Stockholders' Equity (Details) [Line Items]  
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 9,000
Allocated Share-based Compensation Expense $ 81,395